Knome to sequence 20 genomes this year

Knome, the brainchild of renowned Harvard geneticist George Church, is reportedly on track to sequence the genomes of 20 people this year. Knome garnered worldwide attention for its plans to offer full sequencing information on individuals at a price of $350,000. A slate of start-ups including 23andMe and Navigenics have popped up to offer much more limited genetic analysis to consumers interested in finding out more about the risks they face for certain diseases.

"People assume it's hypochondriacs coming to us," Knome CEO Jorge Conde tells the Boston Globe. "It isn't. It's people who are technophiles and inherently curious about themselves, and about science."

- read the article from the Boston Globe

Suggested Articles

The data, from two patients with severe blood disorders, are "promising” for what could be a one-and-done treatment, Cantor Fitzgerald analysts wrote.

The fund will back pharma companies as well as developers of medtech products and providers of outsourced services.

The money will fund work to develop polymers in multiple indications and an associated U.S. expansion.